Sign In
Buy GLPG
$27.38
+0.0650 (+0.238%)
At Close: Jun 03, 2026
Jyseleca® goedgekeurd voor colitis ulcerosa in Japan
06:01am, Monday, 28'th Mar 2022 GlobeNewswire Inc.
Goedkeuring van tweede indicatie gebaseerd op fase 2b/3 SELECTION-studie bij patiënten met matige tot ernstige colitis ulcerosa
Jyseleca® approved in Japan for ulcerative colitis
06:01am, Monday, 28'th Mar 2022 GlobeNewswire Inc.
Approval of additional indication based on Phase 2b/3 SELECTION study in patients with moderate-to-severe ulcerative colitis
Correction: Galapagos publiceert 2021 jaarverslag en kondigt buitengewone en jaarlijkse aandeelhoudersvergaderingen aan
08:17pm, Thursday, 24'th Mar 2022 GlobeNewswire Inc.
-- Voorstel tot one-tier bestuursmodel en benoeming van drie nieuwe bestuurders -- Mechelen, België; 24 maart 2022, 21.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GL
Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
08:17pm, Thursday, 24'th Mar 2022 GlobeNewswire Inc.
-- Proposal of one-tier board structure & appointment of three new directors -- Mechelen, Belgium; 24 March 2022, 21.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) published
Galapagos publiceert 2021 jaarverslag en kondigt buitengewone en jaarlijkse aandeelhoudersvergaderingen aan
08:01pm, Thursday, 24'th Mar 2022 GlobeNewswire Inc.
-- Voorstel tot one-tier bestuursmodel en benoeming van drie nieuwe bestuurders -- Mechelen, België; 24 maart 2021, 21.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GL
Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
08:01pm, Thursday, 24'th Mar 2022 GlobeNewswire Inc.
-- Proposal of one-tier board structure & appointment of three new directors -- Mechelen, Belgium; 24 March 2022, 21.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) published
Galapagos increases share capital through subscription right exercises
09:01pm, Friday, 18'th Mar 2022 GlobeNewswire Inc.
Mechelen, Belgium; 18 March 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right exercises.
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
09:01pm, Friday, 18'th Mar 2022 GlobeNewswire Inc.
Mechelen, België; 18 maart 2022, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) kondigt een kapitaalverhoging aan als gevolg van de uitoefening van inschrijvingsr
Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2021 Update
05:33am, Monday, 28'th Feb 2022 Seeking Alpha
David Einhorn's GLRE 13F stock portfolio value increased from $1.49B to $1.75B this quarter. The largest 3 positions are at ~48% of the portfolio.
Galapagos NV (GLPG) CEO Onno van de Stolpe on Q4 2021 Results - Earnings Call Transcript
05:48pm, Friday, 25'th Feb 2022 Seeking AlphaGalapagos NV (GLPG) CEO Onno van de Stolpe on Q4 2021 Results - Earnings Call Transcript
12:48pm, Friday, 25'th Feb 2022
Galapagos NV (GLPG) CEO Onno van de Stolpe on Q4 2021 Results - Earnings Call Transcript
Galapagos GAAP EPS of -€1.58, revenue of €484.85M
09:07pm, Thursday, 24'th Feb 2022 Seeking Alpha
Galapagos press release (GLPG): FY GAAP EPS of -€1.58.Revenue of €484.85M (+1.4% Y/Y).Cash and current financial investments of €4.7 billion on 31 December 2021Operational cash burn…
Galapagos 2021 results set stage for future growth
09:01pm, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
Key 2021 and post period events:
Resultaten Galapagos 2021 zetten de toon voor toekomstige groei
09:01pm, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
2021 belangrijkste en recente gebeurtenissen:
Galapagos: A History Of Disruptive Failures
06:36am, Tuesday, 22'nd Feb 2022
Galapagos has failed to prove the mettle of its R&D pipeline in most of the programs it ran.
